NCT02794675View on ClinicalTrials.gov

Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 21, 2016

Primary Completion Date

July 24, 2020

Study Completion Date

July 24, 2020

Conditions
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Interventions
DRUG

Cesium 131

The number sources and activity will be based on the target volume to deliver total radiation dose, this will vary per patient.

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT02794675 - Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer | Biotech Hunter | Biotech Hunter